Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Oral Ondansetron

Preclinical

SState University of New York at Buffalo

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2027

PreclinicalRecruiting

Vomiting

NCT05418244

Clinical

Trials by Indication[1]

Vomiting1 trial

Inhaled Isopropyl Alcohol for the Treatment of Nausea in a Pediatric Emergency Department: A Open Label, Randomized Controlled Clinical Trial

Recruiting·SState University of New York at Buffalo·Preclinical·NCT05418244·84 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Oral Ondansetron. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Oral Ondansetron. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — State University of New York at Buffalo company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: SState University of New York at Buffalo

Related News